Medicare Enrolled
Dr. Alan Fein, MD
Pulmonary Disease · Lake Success, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fein
Dr. Alan Fein is a pulmonary disease specialist in Lake Success, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fein performed 2,355 Medicare services across 1,803 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fein received a total of $39,311 from 41 pharmaceutical and/or device companies across 744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in NY
$39,311 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,355
Medicare services
Top 18% in NY for pulmonary disease
1,803
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
673 | $115 | $418 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
306 | $81 | $302 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
276 | $25 | $157 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
131 | $53 | $290 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
115 | $17 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $144 | $587 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
78 | $8 | $32 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
65 | $50 | $251 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
65 | $41 | $215 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
56 | $8 | $34 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
53 | $104 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $164 | $555 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
50 | $10 | $44 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
48 | $118 | $605 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
44 | $36 | $180 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
43 | $81 | $430 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
37 | $31 | $160 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
32 | $51 | $265 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
25 | $36 | $95 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $76 | $280 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
19 | $38 | $148 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
17 | $3 | $10 |
| New patient office visit, complex (60-74 min) | 16 | $197 | $746 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
15 | $283 | $1,115 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
15 | $36 | $95 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
14 | $37 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$39,311
Total received (2018-2024)
Avg $5,616/year across 7 years
Top 8% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
744
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,331 (41.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,394 (36.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,586 (21.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,516
2023
$2,839
2022
$4,813
2021
$3,491
2020
$3,795
2019
$15,893
2018
$5,963
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$505
GlaxoSmithKline, LLC.
$417
Amgen Inc.
$232
Mylan Specialty L.P.
$231
Actelion Pharmaceuticals US, Inc.
$199
Regeneron Healthcare Solutions, Inc.
$179
Insmed, Inc.
$118
Philips North America LLC
$110
GENZYME CORPORATION
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$99
Melinta Therapeutics, LLC
$67
HARMONY BIOSCIENCES LLC
$63
Harmony Biosciences Llc
$59
SANOFI-AVENTIS U.S. LLC
$57
Electromed, Inc.
$29
Axsome Therapeutics, Inc.
$26
Genentech USA, Inc.
$24
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
Insmed, Inc.
$18,302
AstraZeneca Pharmaceuticals LP
$5,474
GlaxoSmithKline, LLC.
$3,883
Nabriva Therapeutics, plc
$1,783
Regeneron Healthcare Solutions, Inc.
$1,185
Mylan Specialty L.P.
$1,178
Actelion Pharmaceuticals US, Inc.
$1,120
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,067
Amgen Inc.
$803
GENZYME CORPORATION
$556
Sunovion Pharmaceuticals Inc.
$546
Philips Electronics North America Corporation
$417
Harmony Biosciences LLC
$399
Genentech USA, Inc.
$384
Electromed, Inc.
$294
Grifols USA, LLC
$161
SANOFI-AVENTIS U.S. LLC
$154
Eisai Inc.
$145
Mallinckrodt Hospital Products Inc.
$127
Philips North America LLC
$110
Merck Sharp & Dohme Corporation
$100
Merck Sharp & Dohme LLC
$88
JAZZ PHARMACEUTICALS INC.
$87
HARMONY BIOSCIENCES LLC
$87
Teva Pharmaceuticals USA, Inc.
$85
PFIZER INC.
$81
Gilead Sciences, Inc.
$68
Melinta Therapeutics, LLC
$67
EISAI INC.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$63
Harmony Biosciences Llc
$59
Advanced Respiratory, Inc
$56
Circassia Pharmaceuticals Inc
$53
Bayer HealthCare Pharmaceuticals Inc.
$49
Novartis Pharmaceuticals Corporation
$42
IDORSIA PHARMACEUTICALS US INC
$36
Apria Healthcare LLC
$34
Baxter Healthcare
$32
Axsome Therapeutics, Inc.
$26
ADVANCED RESPIRATORY, INC
$22
Shire North American Group Inc
$21
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · Arikayce · BELSOMRA · BREO · BREZTRI · BROVANA · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · DreamStat Cpap Auto · Dymista · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · JANUVIA · LONHALA MAGNAIR · Letairis · Medela · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · Rezzayo · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xenleta · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (42%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
595
Per 100K population
42.9
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fein is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NY), with speaking/promotional industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fein performed 673 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fein receive payments from pharmaceutical companies?
Yes. Dr. Fein received a total of $39,311 from 41 companies across 744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fein's costs compare to other pulmonary diseases in Lake Success?
Dr. Fein's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Lake Success
Browse pulmonary diseases in Lake Success ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology